학술논문

Tongue necrosis secondary to giant cell arteritis, successfully treated with tocilizumab: a case report
Document Type
article
Source
BMC Musculoskeletal Disorders, Vol 24, Iss 1, Pp 1-9 (2023)
Subject
Giant cell arteritis
Tongue necrosis
Tocilizumab
Refractory
Case report
Diseases of the musculoskeletal system
RC925-935
Language
English
ISSN
1471-2474
Abstract
Abstracts Background Giant Cell Arteritis (GCA) is a large vessel vasculitis that most commonly presents with headache, scalp tenderness, jaw claudication, and vision changes. Various other, less common, manifestations have been reported in the literature such as scalp and tongue necrosis. Though most patients respond to corticosteroids, some cases of GCA are refractory to the high doses of corticosteroids. Case presentation We present a 73-year-old female with GCA refractory to corticosteroids presenting with tongue necrosis. This patient significantly improved with a dose of tocilizumab, an IL-6 inhibitor. Conclusion To the best of our knowledge, this is the first case report of a patient with refractory GCA presenting with tongue necrosis that had rapid improvement with tocilizumab. Prompt diagnosis and treatment can prevent severe outcomes such as tongue amputation in GCA patients with tongue necrosis, and tocilizumab may be effective for corticosteroid-refractory cases.